Silk rockets and 3D printing: Researchers looks to transform drug delivery

The rockets are made using 3D-printed silk. Image: silkworm, iStock/volkanbys

Engineers from the University of Sheffield have developed 3D-printed silk 'micro-rockets' they say could be used to improve drug delivery.

The thickness of a single human hair, the ‘rockets’ are produced using a solution of dissolved silk mixed with an enzyme which is then printed using a 3D inkjet printer. Methanol is then printed on top, and the methanol molecules trigger a reaction with the enzyme propelling the rocket forward.

When drug molecules are then attached, the formulation becomes a safe drug delivery platform, explained Dr Xiubo Zhao from the Department of Chemical and Biological Engineering at University of Sheffield 

“Many pharmaceutical ingredients - antibodies, DNAs/RNAs, proteins/peptides etc - could be incorporated into the silk micro rockets,” he told in-Pharmatechnologist.com.

“We can simply blend them into the silk ink before printing as long as these pharmaceutical ingredients do not significantly change the properties of the silk ink.”

He added: “The other way to attach the ingredients is to covalently react with printed rocket. This is particularly useful for antibodies [and] receptors which work at the surfaces. This can be done through reactive inkjet printing at the end of the fabrication process. And this is also one of the advantages of this fabrication technology.”

The team of engineers in Sheffield, UK believe the delivery system can offer pharma firms a safe and flexible platform for delivering drugs into patients due to the degradable nature of silk within biological systems.

“Our [rockets] are made of silk which is a protein from silk worm and can be degrade into amino acids,” said Zhao, who added it is a US FDA approved biomaterial widely used in many medical applications.

“Previous devices need metal evaporation of, for example, e.g. Platinum as a catalyst layer for generating the power. This step is more expensive and complex than printing. Platinum cannot be degraded and will cause biofouling due to the adsorption of proteins, hydrocarbons onto the surface.”

The research was funded through a grant from the UK’s Engineering and Physical Sciences Research Council (EPSRC).

“We have not tried to approach any Pharma in this research yet,” Zhao told us. “We would be happy if any Pharma company have interest to work with us to develop this into real world applications.”

Related News

Ravikumar Majeti, Ph.D. is a professor of pharmaceutical sciences at the Texas A&M Irma Lerma Rangel College of Pharmacy, and his team at work in his lab. (Image: Texas A&M Health Science Center)

Pharmacy researchers work to improve drug delivery

PharmaJet's Tropis device delivers medications and vaccines intradermally by means of a narrow, high velocity fluid stream, which penetrates the skin and delivers the medicine or vaccine into the dermis. (Image: iStock/designer491)

Needle-free tech company partners with WHO as part of polio eradication effort

Image: iStock/cosinart

Sartorius awarded US patent for single-use biological 3D printer

"Its just like the way fluff attaches to clothes or gloves in winter. So this is about using nanoparticles to absorb large amounts of proteins via charge interactions," one scientist said.

Harvard develops new nanoparticle as drug delivery device

Gold nanoparticles can cut blood supply to tumours, say researchers

'Nested' nanoparticles increase efficiency of drug delivery

Micromacinazione to get bigger through Neo-Micro deal

Micromacinazione to get bigger through Neo-Micro deal

Related Products

See more related products